You can:
Name | Galanin receptor type 3 |
---|---|
Species | Homo sapiens (Human) |
Gene | GALR3 |
Synonym | GAL3-R Galnr3 GALR-3 GALR3 GAL3 receptor |
Disease | Cognitive disorders |
Length | 368 |
Amino acid sequence | MADAQNISLDSPGSVGAVAVPVVFALIFLLGTVGNGLVLAVLLQPGPSAWQEPGSTTDLFILNLAVADLCFILCCVPFQATIYTLDAWLFGALVCKAVHLLIYLTMYASSFTLAAVSVDRYLAVRHPLRSRALRTPRNARAAVGLVWLLAALFSAPYLSYYGTVRYGALELCVPAWEDARRRALDVATFAAGYLLPVAVVSLAYGRTLRFLWAAVGPAGAAAAEARRRATGRAGRAMLAVAALYALCWGPHHALILCFWYGRFAFSPATYACRLASHCLAYANSCLNPLVYALASRHFRARFRRLWPCGRRRRHRARRALRRVRPASSGPPGCPGDARPSGRLLAGGGQGPEPREGPVHGGEAARGPE |
UniProt | O60755 |
Protein Data Bank | N/A |
GPCR-HGmod model | O60755 |
3D structure model | This predicted structure model is from GPCR-EXP O60755. |
BioLiP | N/A |
Therapeutic Target Database | T98494 |
ChEMBL | CHEMBL2731 |
IUPHAR | 245 |
DrugBank | N/A |
Name | MLS000519909 |
---|---|
Molecular formula | C26H30N4O5 |
IUPAC name | 7-[4-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbonyl]-3-pentyl-1H-quinazoline-2,4-dione |
Molecular weight | 478.549 |
Hydrogen bond acceptor | 6 |
Hydrogen bond donor | 1 |
XlogP | 3.0 |
Synonyms | 7-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazine-1-carbonyl)-3-pentylquinazoline-2,4(1H,3H)-dione MLS000519909-02 7-[[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-oxomethyl]-3-pentyl-1H-quinazoline-2,4-dione F6548-0886 SMR000130324 [ Show all ] |
Inchi Key | CIEDGRWWCWXCMK-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C26H30N4O5/c1-2-3-4-9-30-25(32)20-7-6-19(15-21(20)27-26(30)33)24(31)29-12-10-28(11-13-29)16-18-5-8-22-23(14-18)35-17-34-22/h5-8,14-15H,2-4,9-13,16-17H2,1H3,(H,27,33) |
PubChem CID | 9551471 |
ChEMBL | CHEMBL1319304 |
IUPHAR | N/A |
BindingDB | 48658 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 147.93 nM | , PubChem BioAssay data set | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417